Our technology is being used in different clinical trials, demonstrating their potential to gather data on a range of factors such as lifestyle, environmental exposures, medication use, and patient-reported outcomes. This comprehensive approach allows researchers to analyze data in a more nuanced way, leading to more precise and effective treatments for patients.
Nia
Sorea
milderma
Urticaria App Chronic Rhinosinusitis App Sunburn App
Nia Health and the University of Augsburg receive €30,000 in funding from the EU Agency for the Space Programme. The innovative ADEN platform combines Copernicus
Berlin, 15.5.2023 – Nia Health, ein Spin-off der Berliner Universitätsmedizin Charité, bietet digitale Lösungen für die Behandlung und Unterstützung von Betroffenen mit chronischen Hauterkrankungen. Zu
Berlin, 15.5.2023 – Nia Health, a spin-off of Charité Universitätsmedizin Berlin, offers digital solutions for the treatment and support of sufferers of chronic skin conditions.
Berlin, 02/16/2023. Nia Health GmbH, manufacturer of the atopic dermatitis app Nia, and the healthcare company Sanofi will continue and further expand their successful collaboration
Berlin/Neu-Isenburg, December 19, 2022. Berlin-based Nia Health GmbH and Neu-Isenburg-based pharmaceutical company LEO Pharma have agreed to expand their cooperation. Together, the digital therapy management
Berlin/Hamburg, den 19.10.2022: Das Berliner Digital Health-Unternehmen Nia HealthGmbH und der Deutsche Psoriasis (Schuppenflechte) ist eine chronisch-entzündliche Erkrankung, die durch schuppende und juckende Hautausschläge gekennzeichnet
Are you interested in an innovative, medical solution based on our proven tech infrastructure? Let’s build something great together!
